NCT00722293 2017-11-13A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsGlaxoSmithKlinePhase 1 Completed111 enrolled
NCT00025441 2013-12-04Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsNational Cancer Institute (NCI)Phase 2 Completed